SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE601.007.55 (+1.27 %)
PREV CLOSE ( ) 593.45
OPEN PRICE ( ) 593.45
BID PRICE (QTY) 601.00 (279)
OFFER PRICE (QTY) 601.30 (170)
VOLUME 84587
TODAY'S LOW / HIGH ( )590.05 604.25
52 WK LOW / HIGH ( )434.8 678.8
NSE603.159.7 (+1.63 %)
PREV CLOSE( ) 593.45
OPEN PRICE ( ) 591.90
BID PRICE (QTY) 603.15 (22)
OFFER PRICE (QTY) 603.20 (200)
VOLUME 1860699
TODAY'S LOW / HIGH( ) 590.10 605.00
52 WK LOW / HIGH ( )435 679.3
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Israel Makov - Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
15Oct Sun Pharmaceutical to invest additiona
Sun Pharmaceutical Industries is going to invest an additional Rs 200 cr..
15Oct Sun Pharmaceutical moves up on the bou
Sun Pharmaceutical Industries is currently trading at Rs. 597.60, up by..
09Oct Sun Pharma trades higher on the BSE
Sun Pharmaceutical Industries is currently trading at Rs. 614.60, up by..
04Oct Sun pharma expects to stabilize India
Sun Pharmaceutical Industries is excepting its India business to stabili..
28Sep Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informs about submission of voting res..
Financials
Rs. in Millions
QTR Jun 18 ANNUAL 18
Net Profit2593.9-4945.9
Gross Profit 2596 -5199.8
Operating Profit 5375.812510.6
Net Sales 26075.279476
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Mercury Laboratories (BSE)
 419.90 (4.97%)
M.Cap (Rs. in Cr)50.39
Biocon (BSE)
 655.00 (2.93%)
M.Cap (Rs. in Cr)39429.00
Sanofi India (BSE)
 5933.00 (0.29%)
M.Cap (Rs. in Cr)13700.46
Neuland Laboratories (BSE)
 585.00 (2.27%)
M.Cap (Rs. in Cr)750.55
Astrazeneca Pharma I (BSE)
 1665.50 (0.77%)
M.Cap (Rs. in Cr)4156.88
Shareholding Pattern
PROMOTERS 54.38%
NON-INSTITUTION 12.64%
MUTUAL FUNDS/UTI 8.5%
FI/BANKS/INSURANCE 8.04%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal,Apurva Mittal, Tel no: 022-40790032,022 - 40790024, Mobile no- 9773104340,9768009000 E-mail id- Complaince@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.